Document:

Form of Restricted Stock Unit Agreement

 EXHIBIT 10.3.3 
 NATUS MEDICAL INCORPORATED 
 2000 STOCK AWARDS PLAN 
 NOTICE OF RESTRICTED STOCK UNIT GRANT 
 GRANT NUMBER:               
 The terms defined in the Natus Medical Incorporated 2000 Stock Awards Plan, as amended from time to time (the “Plan”), shall have the same meanings in this Notice of Restricted Stock Unit Grant (the
“Notice of Grant”). 
  

			
		
	 Name:
	 	 
		
	 Address:
	 	 
		
		 	 

 You (the “Participant”)
have been granted an award of Restricted Stock Units (“RSUs”), subject to the terms and conditions of the Plan and the attached Restricted Stock Unit Agreement (hereinafter, the
“RSU Agreement”) to the Plan (available in hard copy by request), as follows: 
  

			
		
	 Number of RSUs:
	 	 
		
	 Date of Grant:
	 	 
		
	 First Vesting Date:
	 	 
		
	 Expiration Date:
	 	The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date
	
	 Vesting Schedule: The RSUs will vest as follows: [Subject to your continued service as a Service Provider,
            .]

 Participant understands that his or her status as a Service Provider is for an unspecified
duration, can be terminated at any time (i.e., is “at-will”), and that nothing in this Notice of Grant, the RSU Agreement or the Plan changes the at-will nature of that relationship. Participant acknowledges that the vesting of the RSUs
pursuant to this Notice of Grant is earned only by continuing service a Service Provider. Participant also understands that this Notice of Grant is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are
incorporated herein by reference. Participant has read both the RSU Agreement and the Plan. 
  

									
	PARTICIPANT:	 		 	NATUS MEDICAL INCORPORATED
					
	Signature:	 	 	 		 	By:	 	 
					
	Print Name:	 	 	 		 	Its:	 	 
					
	Date:	 	 	 		 	Date:	 	 

 NATUS MEDICAL INCORPORATED 
 2000 STOCK AWARDS PLAN 
 RESTRICTED STOCK UNIT AGREEMENT

 Unless otherwise defined herein, the terms defined in the Natus Medical Incorporated 2000 Stock Awards Plan, as
amended from time to time (the “Plan”), shall have the same defined meanings in this Restricted Stock Unit Agreement (the “Agreement”). 
 Participant has been granted Restricted Stock Units (“RSUs”) subject to the terms, restrictions and conditions of
the Plan, the Notice of Restricted Stock Unit Grant (the “Notice of Grant”) and this Agreement. 
 1. SETTLEMENT. Settlement of RSUs shall be made within 30 days following the applicable date of vesting under the vesting schedule set forth in the Notice of Grant. Settlement of RSUs shall be in Shares. 
 2. STOCKHOLDER RIGHTS. Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have
no ownership of the Shares allocated to the RSUs and shall have no right dividends or to vote such Shares. 
 3.
DIVIDEND EQUIVALENTS. Dividends, if any, that are made in the form of cash or property other than Shares, shall not be credited to Participant with respect to RSUs. Dividends in the form of Shares shall be treated as effectively a stock
split and shall result in an appropriate adjustment in the number of RSUs. 
 4. NON-TRANSFERABLE. The
RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of. 
 5. TERMINATION. If Participant’s status as a Service Provider terminates for any reason, or no reason, all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs shall
immediately terminate. In case of any dispute as to whether such termination has occurred, the Committee shall have sole discretion to determine whether such termination has occurred and the effective date of such termination. 
 6. ACKNOWLEDGEMENT. The Company and Participant agree that the RSUs are granted under and governed by the Notice of Grant,
this Agreement and by the provisions of the Plan (incorporated herein by reference). Participant: (a) acknowledges receipt of a copy of the Plan and the Plan prospectus, (b) represents that Participant has carefully read and is familiar
with their provisions, and (c) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant. 
 7. TAX CONSEQUENCES. Participant acknowledges that there will be tax consequences upon settlement of the RSUs or disposition of the Shares, if any, received in connection therewith,
and Participant should consult a tax adviser regarding Participant’s tax obligations prior to such settlement or disposition. Upon vesting of the RSU, Participant will include in income the fair market value of the Shares subject to the RSU.
The included amount will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law. Before any Shares subject to this Agreement are issued Participant must pay to the Company an
amount equal to the minimum amount the Company is required to withhold for income and employment taxes, provided that in its sole discretion the Company may instead elect to deduct from the number of Shares being issued on settlement a number of
Shares with a fair market value (determined on the date the Shares are issued) equal to the minimum amount the Company is required to withhold for income and employment taxes. Upon disposition of the Shares, any subsequent increase or decrease in
value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of settlement. 
 8. COMPLIANCE WITH LAWS AND REGULATIONS. The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable foreign, state
and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company’s Common Stock may be listed or quoted at the time of such issuance or transfer. 

 9. SUCCESSORS AND ASSIGNS. The Company may assign any of its rights under
this Agreement. This Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon Participant and
Participant’s heirs, executors, administrators, legal representatives, successors and assigns. 
 10. GOVERNING
LAW; SEVERABILITY. The Plan and Notice of Grant are incorporated herein by reference. The Plan, the Notice of Grant and this Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in
their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof. This Agreement is governed by Delaware law except for that body of law pertaining to conflict of laws. If any provision of
this Agreement is determined by a court of law to be illegal or unenforceable, then such provision will be enforced to the maximum extent possible and the other provisions will remain fully effective and enforceable. 
 11. NO RIGHTS AS EMPLOYEE, DIRECTOR OR CONSULTANT. Nothing in this
Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant’s employment, for any reason, with or without cause. 
 By your signature and the signature of the Company’s
representative on the Notice of Grant, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice of Grant and this Agreement. Participant has reviewed the Plan, the Notice of
Grant and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice of Grant and this Agreement. Participant hereby agrees
to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice of Grant and this Agreement. Participant further agrees to notify the Company upon any change in
Participant’s residence address.Natus Medical Incorporated 2000 Director Option Plan

 EXHIBIT 10.4 
 NATUS MEDICAL INCORPORATED 
 2000 DIRECTOR OPTION PLAN 
 (As amended through June 13, 2007) 
 1.
Purposes of the Plan. The purposes of this 2000 Director Option Plan are to attract and retain the best available personnel for service as Outside Directors (as defined herein) of the Company, to provide additional incentive to
the Outside Directors of the Company to serve as Directors, and to encourage their continued service on the Board. 
 All options granted
hereunder shall be nonstatutory stock options. 
 2. Definitions. As used herein, the following definitions shall apply: 
 (a) “Board” shall mean the Board of Directors of the Company. 
 (b) “Code” shall mean the Internal Revenue Code of 1986, as amended. 
 (c) “Common Stock” shall mean the common stock of the Company. 
 (d) “Company” shall mean Natus Medical Incorporated, a Delaware corporation. 
 (e) “Director” shall mean a member of the Board. 
 (f) “Disability” shall mean total and permanent disability as defined in section 22(e)(3) of the Code. 
 (g) “Employee” shall mean any person, including officers and Directors employed by the Company or any Parent or Subsidiary of the Company. The payment of a Director’s fee by the Company shall not
be sufficient in and of itself to constitute “employment” by the Company. 
 (h) “Exchange Act” shall mean the
Securities Exchange Act of 1934, as amended. 
 (i) “Fair Market Value” shall mean as of any date, the value of Common Stock
determined as follows: 
 (i) If the Common Stock is listed on any established stock exchange or a national market system, including without
limitation the Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or
system for the last market trading day prior to the time of determination as reported in The Wall Street Journal or such other source as the Administrator deems reliable; 
 (ii) If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Share of
Common Stock shall be the mean between the high bid and low asked prices for the Common Stock for the last market trading day prior to the time of determination, as reported in The Wall Street Journal or such other source as the Board deems
reliable; or 
 (iii) In the absence of an established market for the Common Stock, the Fair Market Value thereof shall be determined in
good faith by the Board. 

 (j) “Inside Director” shall mean a Director who is an Employee. 
 (k) “Option” shall mean a stock option granted pursuant to the Plan. 
 (l) “Optioned Stock” shall mean the Common Stock subject to an Option. 
 (m) “Optionee” shall mean a Director who holds an Option. 
 (n) “Outside Director” shall mean a Director who is not an Employee of the Company. 
 (o)
“Parent” shall mean a “parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code. 
 (p) “Plan” shall mean this 2000 Director Option Plan. 
 (q) “Share” shall
mean a share of the Common Stock, as adjusted in accordance with Section 10 of the Plan but after accounting for the 2-for-5 reverse stock split effected in July 2000. 
 (r) “Subsidiary” shall mean a “subsidiary corporation,” whether now or hereafter existing, as defined in Section 424(f)
of the Internal Revenue Code of 1986. 
 3. Stock Subject to the Plan. Subject to the provisions of
Section 10 of the Plan, the maximum aggregate number of Shares which may be optioned and sold under the Plan is 400,000 Shares (post-split) (the “Pool”) (the Shares may be authorized, but unissued, or reacquired Common Stock),
together with an annual increase to the number of Shares reserved thereunder on the first day of the Company’s fiscal year, beginning with January 1, 2002, equal to the lesser of (i) 100,000 Shares (post-split), (ii) one-half of
one percent (.5%) of the outstanding Shares of Common Stock on the last day of each prior fiscal year or (iii) such amount as determined by the Board. 
 If an Option expires or becomes unexercisable without having been exercised in full, the unpurchased Shares which were subject thereto shall become available for future grant or sale under the Plan (unless the Plan
has terminated). Shares that have actually been issued under the Plan shall not be returned to the Plan and shall not become available for future distribution under the Plan. 
 4. Administration and Grants of Options under the Plan. 
 (a) Procedure for Grants. All grants of Options to Outside Directors under this Plan shall be automatic and nondiscretionary and shall be made strictly in accordance with the following provisions: 

(i) No person shall have any discretion to select which Outside Directors shall be granted Options or to determine the number of Shares to be covered
by Options. 
 (ii) Each Outside Director shall be automatically granted an Option to purchase Shares (the “First Option”) on the
date on which the later of the following events occurs: (A) the effective date of this Plan, as determined in accordance with Section 6 hereof; or (B) the date on which such person first becomes an Outside Director, whether through
election by the stockholders of the Company or appointment by the Board to fill a vacancy; provided, however, that an Inside Director who ceases to be an Inside Director but who remains a Director shall not receive a First Option. The First Option
for an Outside Director who has not previously received a stock option grant from the Company shall be for 22,500 Shares (post-split), and an Outside Director who has previously received a stock option grant from the Company shall not receive a
First Option. 

 (iii) Each Outside Director shall subsequently be automatically granted an Option to purchase Shares (a
“Subsequent Option”) on the date of the next meeting of the Board following the Annual Meeting of Stockholders in each year commencing with the 2001 Annual Meeting of Stockholders provided he or she is then an Outside Director and if as of
such date, he or she shall have served on the Board for at least the preceding six (6) months. The Subsequent Option shall be for 5,000 Shares (post-split). 
 (iv) Notwithstanding the provisions of subsections (ii) and (iii) hereof, any exercise of an Option granted before the Company has obtained stockholder approval of the Plan in accordance with Section 16
hereof shall be conditioned upon obtaining such stockholder approval of the Plan in accordance with Section 16 hereof. 
 (v) The terms
of a First Option granted hereunder shall be as follows: 
 (A) the term of the First Option shall be six (6) years. 
 (B) the First Option shall be exercisable only while the Outside Director remains a Director of the Company, except as set forth in Sections 8 and 10
hereof. 
 (C) the exercise price per Share shall be 100% of the Fair Market Value per Share on the date of grant of the First Option
provided, however, that in the case of a First Option granted on the effective date of the Company’s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission, the exercise price per share
shall be the initial public offering price per share. 
 (D) subject to
Section 10 hereof, the First Option shall become exercisable as to 1/36th of the Shares subject to the First Option each month after the date
of grant, so that the First Option shall be fully exercisable 3 years after its date of grant, provided that the Optionee continues to serve as a Director on such dates. 
 (vi) The terms of a Subsequent Option granted hereunder shall be as follows: 
 (A) the term of the
Subsequent Option shall be six (60 years. 
 (B) the Subsequent Option shall be exercisable only while the Outside Director remains a
Director of the Company, except as set forth in Sections 8 and 10 hereof. 
 (C) the exercise price per Share shall be 100% of the Fair
Market Value per Share on the date of grant of the Subsequent Option. 
 (D) subject
to Section 10 hereof, the Subsequent Option shall become exercisable cumulatively with respect to  1/12th of the Subsequent Option at the end of each month after the date of grant, so that the Subsequent Option shall be fully exercisable 1 year after its date of
grant, provided that the Optionee continues to serve as a Director on such dates. 
 (vii) In the event that any Option granted under
the Plan would cause the number of Shares subject to outstanding Options plus the number of Shares previously purchased under Options to exceed the Pool, then the remaining Shares available for Option grant shall be granted under Options to the
Outside Directors on a pro rata basis. No further grants shall be made until such time, if any, as additional 

 
Shares become available for grant under the Plan through action of the Board or the stockholders to increase the number of Shares which may be issued under
the Plan or through cancellation or expiration of Options previously granted hereunder. 
 5. Eligibility. Options may be granted only
to Outside Directors. All Options shall be automatically granted in accordance with the terms set forth in Section 4 hereof. 
 The Plan
shall not confer upon any Optionee any right with respect to continuation of service as a Director or nomination to serve as a Director, nor shall it interfere in any way with any rights which the Director or the Company may have to terminate the
Director’s relationship with the Company at any time. 
 6. Term of Plan. The Plan shall become effective upon the
earlier to occur of its adoption by the Board or its approval by the stockholders of the Company as described in Section 16 of the Plan; provided, however, the Plan shall not become effective until the effective date of the Company’s
initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission. It shall continue in effect for a term of ten (10) years unless sooner terminated under Section 11 of the Plan. 
 7. Form of Consideration. The consideration to be paid for the Shares to be issued upon exercise of an Option, including the method of payment,
shall consist of (i) cash, (ii) check, (iii) other shares which (x) in the case of Shares acquired upon exercise of an option, have been owned by the Optionee for more than six (6) months on the date of surrender, and
(y) have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Option shall be exercised, (iv) consideration received by the Company under a cashless exercise program implemented
by the Company in connection with the Plan, or (v) any combination of the foregoing methods of payment. 
 8.
Exercise of Option. 
 (a) Procedure for Exercise; Rights as a Stockholder. Any Option granted hereunder
shall be exercisable at such times as are set forth in Section 4 hereof; provided, however, that no Options shall be exercisable until stockholder approval of the Plan in accordance with Section 16 hereof has been obtained. 
 An Option may not be exercised for a fraction of a Share. 
 An Option shall be deemed to be exercised when written notice of such exercise has been given to the Company in accordance with the terms of the Option by the person entitled to exercise the Option and full payment
for the Shares with respect to which the Option is exercised has been received by the Company. Full payment may consist of any consideration and method of payment allowable under Section 7 of the Plan. Until the issuance (as evidenced by the
appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate evidencing such Shares, no right to vote or receive dividends or any other rights as a stockholder shall exist with respect
to the Optioned Stock, notwithstanding the exercise of the Option. A share certificate for the number of Shares so acquired shall be issued to the Optionee as soon as practicable after exercise of the Option. No adjustment shall be made for a
dividend or other right for which the record date is prior to the date the stock certificate is issued, except as provided in Section 10 of the Plan. 
 Exercise of an Option in any manner shall result in a decrease in the number of Shares which thereafter may be available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to
which the Option is exercised. 
 (b) Termination of Continuous Status as a Director. Subject to Section 10 hereof, in
the event an Optionee’s status as a Director terminates (other than upon the Optionee’s death or Disability), the 

 
Optionee may exercise his or her Option, but only within three (3) months following the date of such termination, and only to the extent that the
Optionee was entitled to exercise it on the date of such termination (but in no event later than the expiration of its six (6) year term). To the extent that the Optionee was not entitled to exercise an Option on the date of such termination,
and to the extent that the Optionee does not exercise such Option (to the extent otherwise so entitled) within the time specified herein, the Option shall terminate. 
 (c) Disability of Optionee. In the event Optionee’s status as a Director terminates as a result of Disability, the Optionee may exercise his or her Option, but only within twelve (12) months following
the date of such termination, and only to the extent that the Optionee was entitled to exercise it on the date of such termination (but in no event later than the expiration of its six (6) year term). To the extent that the Optionee was not
entitled to exercise an Option on the date of termination, or if he or she does not exercise such Option (to the extent otherwise so entitled) within the time specified herein, the Option shall terminate. 
 (d) Death of Optionee. In the event of an Optionee’s death, the Optionee’s estate or a person who acquired the right to
exercise the Option by bequest or inheritance may exercise the Option, but only within twelve (12) months following the date of death, and only to the extent that the Optionee was entitled to exercise it on the date of death (but in no event
later than the expiration of its six (6) year term). To the extent that the Optionee was not entitled to exercise an Option on the date of death, and to the extent that the Optionee’s estate or a person who acquired the right to exercise
such Option does not exercise such Option (to the extent otherwise so entitled) within the time specified herein, the Option shall terminate. 
 9. Non-Transferability of Options. The Option may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the
lifetime of the Optionee, only by the Optionee. 
 10. Adjustments Upon Changes in Capitalization, Dissolution, Merger
or Asset Sale. 
 (a) Changes in Capitalization. Subject to any required action by the stockholders of the Company, the number of
Shares covered by each outstanding Option, the number of Shares which have been authorized for issuance under the Plan but as to which no Options have yet been granted or which have been returned to the Plan upon cancellation or expiration of an
Option, as well as the price per Share covered by each such outstanding Option, and the number of Shares issuable pursuant to the automatic grant provisions of Section 4 hereof shall be proportionately adjusted for any increase or decrease in
the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other increase or decrease in the number of issued Shares effected without receipt of
consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.” Except as expressly provided herein, no issuance by
the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an Option.

 (b) Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, to the extent that an
Option has not been previously exercised, it shall terminate immediately prior to the consummation of such proposed action. 
 (c) Merger
or Asset Sale. In the event of a merger of the Company with or into another corporation or the sale of substantially all of the assets of the Company, outstanding Options may be assumed or equivalent options may be substituted by the successor
corporation or a Parent or Subsidiary thereof (the “Successor Corporation”). If an Option is assumed or substituted for, the Option or equivalent 

 
option shall continue to be exercisable as provided in Section 4 hereof for so long as the Optionee serves as a Director or a director of the Successor
Corporation. Following such assumption or substitution, if the Optionee’s status as a Director or director of the Successor Corporation, as applicable, is terminated other than upon a voluntary resignation by the Optionee, the Option or option
shall become fully exercisable, including as to Shares for which it would not otherwise be exercisable. Thereafter, the Option or option shall remain exercisable in accordance with Sections 8(b) through (d) above. 
 If the Successor Corporation does not assume an outstanding Option or substitute for it an equivalent option, the Option shall become fully vested and
exercisable, including as to Shares for which it would not otherwise be exercisable. In such event the Board shall notify the Optionee that the Option shall be fully exercisable for a period of fifteen (15) days from the date of such notice,
and upon the expiration of such period the Option shall terminate. 
 For the purposes of this Section 10(c), an Option shall be
considered assumed if, following the merger or sale of assets, the Option confers the right to purchase or receive, for each Share of Optioned Stock subject to the Option immediately prior to the merger or sale of assets, the consideration (whether
stock, cash, or other securities or property) received in the merger or sale of assets by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of
consideration chosen by the holders of a majority of the outstanding Shares). If such consideration received in the merger or sale of assets is not solely common stock of the successor corporation or its Parent, the Administrator may, with the
consent of the successor corporation, provide for the consideration to be received upon the exercise of the Option, for each Share of Optioned Stock subject to the Option, to be solely common stock of the successor corporation or its Parent equal in
fair market value to the per share consideration received by holders of Common Stock in the merger or sale of assets. 
 11.
Amendment and Termination of the Plan. 
 (a) Amendment and Termination. The Board may at any time
amend, alter, suspend, or discontinue the Plan, but no amendment, alteration, suspension, or discontinuation shall be made which would impair the rights of any Optionee under any grant theretofore made, without his or her consent. In addition, to
the extent necessary and desirable to comply with any applicable law, regulation or stock exchange rule, the Company shall obtain stockholder approval of any Plan amendment in such a manner and to such a degree as required. 
 (b) Effect of Amendment or Termination. Any such amendment or termination of the Plan shall not affect Options already granted
and such Options shall remain in full force and effect as if this Plan had not been amended or terminated. 
 12.
Time of Granting Options. The date of grant of an Option shall, for all purposes, be the date determined in accordance with Section 4 hereof. 
 13. Conditions Upon Issuance of Shares. Shares shall not be issued pursuant to the exercise of an Option unless the exercise of such Option and the issuance and delivery of such Shares
pursuant thereto shall comply with all relevant provisions of law, including, without limitation, the Securities Act of 1933, as amended, the Exchange Act, the rules and regulations promulgated thereunder, state securities laws, and the requirements
of any stock exchange upon which the Shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such compliance. 
 As a condition to the exercise of an Option, the Company may require the person exercising such Option to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment
and without any present intention to sell or distribute such Shares, if, in the opinion of counsel for the Company, such a representation is required by any of the aforementioned relevant provisions of law. 

 Inability of the Company to obtain authority from any regulatory body having jurisdiction, which
authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite
authority shall not have been obtained. 
 14. Reservation of Shares. The Company, during the term of this Plan, will at all
times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan. 
 15. Option
Agreement. Options shall be evidenced by written option agreements in such form as the Board shall approve. 
 16. Stockholder
Approval. The Plan shall be subject to approval by the stockholders of the Company within twelve (12) months after the date the Plan is adopted. Such stockholder approval shall be obtained in the degree and manner required under applicable
state and federal law and any stock exchange rules.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]